{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:34Z","timestamp":1790983114346,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"DOI":"10.1007\/s13760-026-03149-y","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:04Z","timestamp":1786167784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent ischemic strokes with normal inflammatory markers: when tests mislead"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4899-5429","authenticated-orcid":false,"given":"Isabel Ros","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P\u00e9rez","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Mart\u00edn","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alexandra Figueroa","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Fontsere","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Hormigos","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Torrico","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"De La Calle Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"3149_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1305093","volume":"14","author":"M Bonnan","year":"2023","unstructured":"Bonnan M, Debeugny S (2023) Giant-cell arteritis related strokes: scoping review of mechanisms and rethinking treatment strategy? Front Neurol 14:1305093. https:\/\/doi.org\/10.3389\/fneur.2023.1305093","journal-title":"Front Neurol"},{"issue":"2","key":"3149_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1468-1331.2001.00180.x","volume":"8","author":"A Arboix","year":"2001","unstructured":"Arboix A, Bechich S, Oliveres M, Garc\u00eda-Eroles L, Massons J, Targa C (2001) Ischemic stroke of unusual cause: clinical features, etiology and outcome. Eur J Neurol 8(2):133\u2013139. https:\/\/doi.org\/10.1046\/j.1468-1331.2001.00180.x","journal-title":"Eur J Neurol"},{"key":"3149_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223480","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A et al (2022) 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3149_CR4","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1093\/rheumatology\/keaf049","volume":"64","author":"S Parreau","year":"2025","unstructured":"Parreau S, Cayrou C, Dumonteil S, Laburthe S, Bosphore G, Desvaux E et al (2025) Giant cell arteritis mimics with severe consequences: a long-term monocentric inception cohort. Rheumatology (Oxford) 64(8):4726\u20134731. https:\/\/doi.org\/10.1093\/rheumatology\/keaf049","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3149_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s13760-020-01344-z","volume":"120","author":"AM Elhfnawy","year":"2020","unstructured":"Elhfnawy AM, Elsalamawy D, Abdelraouf M, Schliesser M, Volkmann J, Fluri F (2020) Red flags for a concomitant giant cell arteritis in patients with vertebrobasilar stroke: a cross-sectional study and systematic review. Acta Neurol Belg 120(6):1389\u20131398. https:\/\/doi.org\/10.1007\/s13760-020-01344-z","journal-title":"Acta Neurol Belg"},{"issue":"8","key":"3149_CR6","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","volume":"41","author":"MA Gonz\u00e1lez-Gay","year":"1998","unstructured":"Gonz\u00e1lez-Gay MA, Blanco R, Rodr\u00edguez-Valverde V, Mart\u00ednez-Taboada VM, Delgado-Rodriguez M, Figueroa M et al (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41(8):1497\u20131504. https:\/\/doi.org\/10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","journal-title":"Arthritis Rheum"},{"key":"3149_CR7","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00296-013-2814-0","volume":"33","author":"T Zenone","year":"2013","unstructured":"Zenone T, Puget M (2013) Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis. Rheumatol Int 33:3017\u20133022. https:\/\/doi.org\/10.1007\/s00296-013-2814-0","journal-title":"Rheumatol Int"},{"issue":"5","key":"3149_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.semarthrit.2016.11.002","volume":"46","author":"K Tuckwell","year":"2017","unstructured":"Tuckwell K, Collinson N, Dimonaco S, Klearman M, Blockmans D, Brouwer E et al (2017) Newly diagnosed vs. relapsing giant cell arteritis: baseline data from the GiACTA trial. Semin Arthritis Rheum 46(5):657\u2013664. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.11.002","journal-title":"Semin Arthritis Rheum"},{"key":"3149_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/OPTH.S193460","volume":"13","author":"EB Ing","year":"2019","unstructured":"Ing EB, Miller NR, Nguyen A et al (2019) Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation. Clin Ophthalmol 13:421\u2013430. https:\/\/doi.org\/10.2147\/OPTH.S193460","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"3149_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10194-020-01093-7","volume":"21","author":"SP Mollan","year":"2020","unstructured":"Mollan SP, Paemeleire K, Versijpt J, Luqmani R, Sinclair AJ (2020) European Headache Federation recommendations for neurologists managing giant cell arteritis. J Headache Pain 21(1):28. https:\/\/doi.org\/10.1186\/s10194-020-01093-7","journal-title":"J Headache Pain"},{"issue":"11","key":"3149_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","volume":"72","author":"MA Nagel","year":"2015","unstructured":"Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL et al (2015) Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol 72(11):1281\u20131287. https:\/\/doi.org\/10.1001\/jamaneurol.2015.2101","journal-title":"JAMA Neurol"},{"issue":"4","key":"3149_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003493","volume":"9","author":"L Pacoureau","year":"2023","unstructured":"Pacoureau L, Barde F, Seror R, Nguyen Y (2023) Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. RMD Open 9(4):e003493. https:\/\/doi.org\/10.1136\/rmdopen-2023-003493","journal-title":"RMD Open"},{"key":"3149_CR13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.40520","volume":"70","author":"KSM Van Der Geest","year":"2018","unstructured":"Van Der Geest KSM, Sandovici M, Van Sleen Y, Sanders JS, Bos NA, Abdulahad WH et al (2018) Review: what is the current evidence for disease subsets in giant cell arteritis? Arthritis Rheumatol 70:1366\u20131376. https:\/\/doi.org\/10.1002\/art.40520","journal-title":"Arthritis Rheumatol"},{"key":"3149_CR14","first-page":"S30","volume":"26","author":"G Nesher","year":"2008","unstructured":"Nesher G, Nesher R, Mates M, Sonnenblick M, Breuer GS (2008) Giant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease. Clin Exp Rheumatol 26:S30\u201334 PMID: 18799050","journal-title":"Clin Exp Rheumatol"},{"key":"3149_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.hjc.2024.10.008","volume":"83","author":"SS Rathore","year":"2025","unstructured":"Rathore SS, Srikaram P, Gudena S, Manoj S, Allam SR, Hatamleh MA et al (2025) Risk of cardiovascular events in giant cell arteritis: systematic review and meta-analysis. Hellenic J Cardiol 83:78\u201387. https:\/\/doi.org\/10.1016\/j.hjc.2024.10.008","journal-title":"Hellenic J Cardiol"},{"issue":"90","key":"3149_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20900","volume":"20","author":"R Luqmani","year":"2016","unstructured":"Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M et al (2016) The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1\u2013238. https:\/\/doi.org\/10.3310\/hta20900","journal-title":"Health Technol Assess"},{"issue":"2","key":"3149_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/imj.70315","volume":"56","author":"I Liang","year":"2026","unstructured":"Liang I, Caterson H, Sammel A (2026) Advances in management of giant cell arteritis. Intern Med J 56(2):171\u2013183. https:\/\/doi.org\/10.1111\/imj.70315","journal-title":"Intern Med J"},{"issue":"5","key":"3149_CR18","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1093\/rheumatology\/keae666","volume":"64","author":"R Blanco","year":"2025","unstructured":"Blanco R, Aldasoro V, Maiz O, Melero R, Romero-Yuste S, de Miguel E et al (2025) Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases. Rheumatology (Oxford) 64(5):2928\u20132936. https:\/\/doi.org\/10.1093\/rheumatology\/keae666","journal-title":"Rheumatology (Oxford)"},{"issue":"1Suppl 64","key":"3149_CR19","first-page":"S43","volume":"29","author":"JC Henes","year":"2011","unstructured":"Henes JC, Mueller M, Pfannenberg C, Kanz L, Koetter I (2011) Cyclophosphamide for large vessel vasculitis: assessment of response by PET\/CT. Clin Exp Rheumatol 29(1Suppl 64):S43\u201348 PMID: 21385544","journal-title":"Clin Exp Rheumatol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03149-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:05Z","timestamp":1786167785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03149-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":19,"alternative-id":["3149"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03149-y","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was conducted in accordance with the ethical standards of the Institutional Review Board of Hospital Universitario Infanta Elena and with the principles of the Declaration of Helsinki. Given the retrospective descriptive nature of this work and the absence of identifiable patient information, formal Ethics Committee approval was waived according to institutional policies. All patient information was fully anonymized, and no identifiable data are included in this manuscript. No images or clinical details compromising patient anonymity are included.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}